Exploring a variant-adapted SARS-CoV-2 recombinant protein vaccine

Digital transformation conceptual for next generation technology era

Researchers assessed the immunogenicity of a variant-adapted severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recombinant protein vaccine boosted with an AS03 adjuvant.

New prostate cancer diagnostic pathway paves way for general screening

Previous article

Coseismic Displacement of 1987 Earthquake from Aerial Images

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News